<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Axenfeld-Rieger_syndrome - Disorder Mechanisms</title>
    <style>
        :root {
            --primary: #0f766e;
            --primary-light: #14b8a6;
            --primary-dark: #0d5c56;
            --secondary: #6366f1;
            --bg: #f0fdfa;
            --card-bg: #ffffff;
            --text: #134e4a;
            --text-muted: #5f7a78;
            --border: #ccfbf1;
            --accent-orange: #f59e0b;
            --accent-rose: #f43f5e;
            --accent-violet: #8b5cf6;
            --accent-sky: #0ea5e9;
            --banner-bg: #fef3c7;
            --banner-border: #f59e0b;
            --banner-text: #92400e;
        }

        * { box-sizing: border-box; margin: 0; padding: 0; }

        body {
            font-family: 'Segoe UI', system-ui, -apple-system, sans-serif;
            background: var(--bg);
            color: var(--text);
            line-height: 1.7;
        }

        .notice-banner {
            background: var(--banner-bg);
            color: var(--banner-text);
            border-bottom: 1px solid var(--banner-border);
            padding: 12px 16px;
            text-align: center;
            font-size: 0.95rem;
            cursor: pointer;
        }

        .container {
            max-width: 1100px;
            margin: 0 auto;
            padding: 24px;
        }

        /* Header */
        .page-header {
            background: linear-gradient(135deg, var(--primary) 0%, var(--primary-dark) 100%);
            color: white;
            padding: 40px 32px;
            border-radius: 16px;
            margin-bottom: 24px;
            position: relative;
            overflow: hidden;
        }

        .page-header::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -20%;
            width: 400px;
            height: 400px;
            background: rgba(255,255,255,0.05);
            border-radius: 50%;
        }

        .page-header h1 {
            font-size: 2.2rem;
            font-weight: 700;
            margin-bottom: 12px;
            position: relative;
        }

        .header-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 12px;
            align-items: center;
            position: relative;
        }

        .badge {
            display: inline-flex;
            align-items: center;
            padding: 6px 14px;
            border-radius: 20px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .badge-category {
            background: rgba(255,255,255,0.2);
            color: white;
        }

        .badge-mondo {
            background: var(--accent-sky);
            color: white;
        }

        .badge-mondo a {
            color: inherit;
            text-decoration: none;
        }

        .badge-mondo a:hover {
            text-decoration: underline;
        }

        /* Navigation */
        .breadcrumb {
            margin-bottom: 16px;
            font-size: 0.9rem;
        }

        .breadcrumb a {
            color: var(--primary);
            text-decoration: none;
        }

        .breadcrumb a:hover {
            text-decoration: underline;
        }

        .breadcrumb span {
            color: var(--text-muted);
        }

        /* Cards */
        .card {
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            padding: 24px;
            margin-bottom: 20px;
            box-shadow: 0 1px 3px rgba(0,0,0,0.04);
        }

        .card-header {
            display: flex;
            align-items: center;
            gap: 12px;
            margin-bottom: 16px;
            padding-bottom: 12px;
            border-bottom: 2px solid var(--border);
        }

        .card-icon {
            width: 36px;
            height: 36px;
            border-radius: 8px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 1.2rem;
        }

        .card-title {
            font-size: 1.1rem;
            font-weight: 600;
            color: var(--text);
        }

        .card-count {
            margin-left: auto;
            background: var(--bg);
            padding: 4px 12px;
            border-radius: 12px;
            font-size: 0.8rem;
            color: var(--text-muted);
        }

        /* Sections */
        .section-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(320px, 1fr));
            gap: 20px;
        }

        /* Tags */
        .tag-list {
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
        }

        .tag {
            padding: 6px 12px;
            border-radius: 6px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .tag-cell {
            background: #fce7f3;
            color: #9d174d;
        }

        .tag-gene {
            background: #dbeafe;
            color: #1e40af;
        }

        .tag-treatment {
            background: #ede9fe;
            color: #5b21b6;
        }

        .tag-env {
            background: #ccfbf1;
            color: #0f766e;
        }

        .tag-location {
            background: #e0e7ff;
            color: #3730a3;
        }

        .tag-component {
            background: #f0fdf4;
            color: #166534;
        }

        .tag-complex {
            background: #faf5ff;
            color: #7e22ce;
        }

        .tag-bio {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-modifier {
            background: #fee2e2;
            color: #991b1b;
            text-transform: uppercase;
            letter-spacing: 0.02em;
        }

        .tag-parent {
            background: #e0e7ff;
            color: #3730a3;
        }

        .tag-classification {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-mechanistic {
            background: #dbeafe;
            color: #1e40af;
        }

        .linkout {
            color: inherit;
            margin-left: 6px;
            font-size: 0.75rem;
            text-decoration: none;
            border-bottom: 1px dotted rgba(0, 0, 0, 0.2);
        }

        .classification-category {
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            color: var(--text-muted);
            margin-bottom: 8px;
        }

        .mapping-section {
            margin-bottom: 16px;
        }

        .mapping-item {
            padding: 10px 12px;
            border: 1px solid #e2e8f0;
            border-radius: 8px;
            background: #ffffff;
            margin-bottom: 10px;
        }

        .mapping-title {
            font-size: 0.9rem;
            font-weight: 600;
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
            align-items: baseline;
            margin-bottom: 6px;
        }

        .mapping-label {
            color: var(--text-muted);
            font-weight: 500;
        }

        .mapping-notes {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 6px;
        }

        .mapping-tree {
            margin-top: 6px;
            font-size: 0.75rem;
            color: var(--text-muted);
            list-style: none;
            padding-left: 0;
        }

        .mapping-tree li {
            margin: 2px 0;
        }

        /* Evidence styling */
        .evidence-toggle {
            cursor: pointer;
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 10px;
            user-select: none;
        }

        .evidence-toggle:hover {
            color: var(--primary);
        }

        .evidence-list {
            margin-top: 10px;
            padding-left: 0;
        }

        .evidence-item {
            padding: 12px 14px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .evidence-header {
            display: flex;
            align-items: center;
            flex-wrap: wrap;
            gap: 8px;
        }

        .evidence-ref {
            font-weight: 600;
            color: var(--secondary);
        }

        .evidence-ref a {
            color: inherit;
            text-decoration: none;
        }

        .evidence-ref a:hover {
            text-decoration: underline;
        }

        .evidence-support {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
            transition: transform 120ms ease, box-shadow 120ms ease;
        }

        .support-SUPPORT { background: #dcfce7; color: #166534; }
        .support-PARTIAL { background: #fef3c7; color: #92400e; }
        .support-REFUTE { background: #fee2e2; color: #991b1b; }
        .support-NO_EVIDENCE { background: #f1f5f9; color: #64748b; }
        .support-WRONG_STATEMENT { background: #fecaca; color: #7f1d1d; }

        .evidence-source {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
            background: #e2e8f0;
            color: #334155;
            transition: transform 120ms ease, box-shadow 120ms ease;
        }

        .evidence-support:hover,
        .evidence-source:hover {
            transform: translateY(-1px);
            box-shadow: 0 4px 10px rgba(0,0,0,0.08);
        }

        .source-HUMAN_CLINICAL { background: #e0f2fe; color: #075985; }
        .source-MODEL_ORGANISM { background: #fef9c3; color: #854d0e; }
        .source-IN_VITRO { background: #ede9fe; color: #5b21b6; }
        .source-COMPUTATIONAL { background: #cffafe; color: #0e7490; }
        .source-OTHER { background: #e5e7eb; color: #374151; }

        .evidence-snippet {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 8px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        .evidence-explanation {
            font-size: 0.85rem;
            color: var(--text);
            margin-top: 6px;
            line-height: 1.5;
        }

        .evidence-more {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 6px;
            font-style: italic;
        }

        .findings-section {
            margin-top: 12px;
        }

        .findings-title {
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: var(--text-muted);
            margin-bottom: 6px;
        }

        .finding-item {
            padding: 10px 12px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .finding-statement {
            font-weight: 600;
            color: var(--text);
            margin-bottom: 6px;
            line-height: 1.5;
        }

        .finding-supporting {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 6px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        /* Item containers with evidence */
        .item-box {
            padding: 16px;
            border-radius: 10px;
            margin-bottom: 12px;
        }

        .item-name {
            font-weight: 600;
            margin-bottom: 6px;
        }

        .item-desc {
            font-size: 0.9rem;
            line-height: 1.6;
            margin-bottom: 8px;
        }

        .item-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            margin-top: 8px;
        }

        /* Definitions */
        .definition-box {
            background: #ecfeff;
            border-left: 4px solid #0ea5e9;
        }
        .definition-box .item-name { color: #0c4a6e; }
        .definition-box .item-desc { color: #075985; }

        /* Inheritance */
        .inheritance-box {
            background: #fef9c3;
            border-left: 4px solid #ca8a04;
        }
        .inheritance-box .item-name { color: #92400e; }
        .inheritance-box .item-desc { color: #92400e; }

        .criteria-block {
            margin-top: 12px;
            padding: 12px;
            border-radius: 8px;
            border: 1px solid #bae6fd;
            background: rgba(255, 255, 255, 0.7);
        }

        .criteria-title {
            font-weight: 600;
            color: #0c4a6e;
            margin-bottom: 6px;
        }

        .criteria-meta {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-bottom: 8px;
        }

        .criteria-header {
            font-size: 0.75rem;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: #0284c7;
            margin-top: 8px;
        }

        .criteria-list {
            margin-left: 18px;
            font-size: 0.9rem;
            line-height: 1.5;
            color: #0f172a;
        }

        .criteria-list li {
            margin-bottom: 6px;
        }

        .criteria-detail {
            display: block;
            font-size: 0.85rem;
            color: var(--text-muted);
        }

        /* Pathophysiology */
        .pathophys-box {
            background: linear-gradient(135deg, #fef3c7 0%, #fef9c3 100%);
            border-left: 4px solid var(--accent-orange);
        }
        .pathophys-box .item-name { color: #92400e; }
        .pathophys-box .item-desc { color: #78350f; }

        /* Histopathology */
        .histopathology-box {
            background: #fff7ed;
            border-left: 4px solid #fb923c;
        }
        .histopathology-box .item-name { color: #9a3412; }
        .histopathology-box .item-desc { color: #c2410c; }

        .histopathology-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #ffedd5;
            color: #c2410c;
        }

        /* Phenotypes */
        .phenotype-box {
            background: #f0fdf4;
            border-left: 4px solid #22c55e;
        }
        .phenotype-box .item-name { color: #166534; }
        .phenotype-box .item-desc { color: #15803d; }

        .phenotype-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #dcfce7;
            color: #15803d;
        }

        .phenotype-category {
            font-size: 0.75rem;
            color: #4ade80;
        }

        .phenotype-id a {
            font-size: 0.8rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .phenotype-id a:hover {
            text-decoration: underline;
        }

        /* Phenotype TOC strip */
        .pheno-toc {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            padding: 10px 0 6px 0;
            border-bottom: 1px solid #e2e8f0;
            margin-bottom: 4px;
        }

        .pheno-toc-pill {
            display: inline-block;
            font-size: 0.78rem;
            padding: 3px 10px;
            border-radius: 12px;
            background: #dcfce7;
            color: #166534;
            text-decoration: none;
            cursor: pointer;
            white-space: nowrap;
            transition: background 0.15s;
        }

        .pheno-toc-pill:hover {
            background: #bbf7d0;
        }

        .pheno-toc-pill .pill-count {
            font-weight: 600;
            margin-left: 2px;
        }

        .pheno-toggle-all {
            font-size: 0.78rem;
            color: #16a34a;
            cursor: pointer;
            background: none;
            border: 1px solid #bbf7d0;
            border-radius: 6px;
            padding: 3px 10px;
            margin-left: auto;
            white-space: nowrap;
            transition: background 0.15s;
        }

        .pheno-toggle-all:hover {
            background: #f0fdf4;
        }

        /* Collapsible category groups */
        .phenotype-category-group {
            margin-bottom: 2px;
        }

        .phenotype-category-group summary {
            font-size: 0.85rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: #16a34a;
            margin: 0;
            padding: 10px 0 6px 0;
            border-bottom: 1px solid #bbf7d0;
            cursor: pointer;
            list-style: none;
            display: flex;
            align-items: center;
            gap: 6px;
        }

        .phenotype-category-group summary::-webkit-details-marker {
            display: none;
        }

        .phenotype-category-group summary .chevron {
            display: inline-block;
            width: 16px;
            height: 16px;
            transition: transform 0.15s;
            flex-shrink: 0;
        }

        .phenotype-category-group[open] summary .chevron {
            transform: rotate(90deg);
        }

        .phenotype-category-group summary .cat-count {
            font-size: 0.75rem;
            font-weight: 400;
            color: #15803d;
            background: #dcfce7;
            padding: 1px 7px;
            border-radius: 8px;
        }

        /* Phenotype Contexts */
        .phenotype-contexts {
            margin-top: 10px;
        }

        .phenotype-contexts-toggle {
            font-size: 0.8rem;
            color: var(--text-muted);
            cursor: pointer;
            user-select: none;
        }

        .phenotype-contexts-toggle:hover {
            color: var(--primary);
        }

        .context-card {
            padding: 10px 14px;
            margin-top: 8px;
            border-radius: 8px;
            background: #ecfdf5;
            border: 1px solid #a7f3d0;
            font-size: 0.88rem;
        }

        .context-header {
            display: flex;
            flex-wrap: wrap;
            align-items: center;
            gap: 6px;
            margin-bottom: 6px;
        }

        .context-label {
            font-size: 0.72rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            padding: 2px 8px;
            border-radius: 4px;
        }

        .context-label-genetic {
            background: #dbeafe;
            color: #1e40af;
        }

        .context-label-sex {
            background: #fce7f3;
            color: #9d174d;
        }

        .context-label-population {
            background: #fef3c7;
            color: #92400e;
        }

        .context-label-age {
            background: #e0e7ff;
            color: #3730a3;
        }

        .context-label-subtype {
            background: #ede9fe;
            color: #5b21b6;
        }

        .context-label-frequency {
            background: #dcfce7;
            color: #166534;
        }

        .context-gene-list {
            display: flex;
            flex-wrap: wrap;
            gap: 4px;
            margin: 4px 0;
        }

        .context-gene-tag {
            font-size: 0.78rem;
            font-weight: 600;
            padding: 1px 8px;
            border-radius: 4px;
            background: #bfdbfe;
            color: #1e3a8a;
        }

        .context-detail {
            font-size: 0.84rem;
            color: #065f46;
            line-height: 1.5;
        }

        .context-detail strong {
            color: #047857;
        }

        .context-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #bbf7d0;
            color: #14532d;
            font-weight: 600;
        }

        .context-onset {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #e0e7ff;
            color: #3730a3;
        }

        .context-severity {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #fef3c7;
            color: #92400e;
        }

        .context-notes {
            font-size: 0.84rem;
            color: #065f46;
            margin-top: 4px;
            line-height: 1.5;
        }

        /* Genetic */
        .genetic-box {
            background: #eff6ff;
            border-left: 4px solid #3b82f6;
        }
        .genetic-box .item-name { color: #1e40af; }
        .genetic-box .item-desc { color: #2563eb; }

        /* Treatment */
        .treatment-box {
            background: #faf5ff;
            border-left: 4px solid #8b5cf6;
        }
        .treatment-box .item-name { color: #5b21b6; }
        .treatment-box .item-desc { color: #7c3aed; }

        /* Environmental */
        .environmental-box {
            background: #f0fdfa;
            border-left: 4px solid #14b8a6;
        }
        .environmental-box .item-name { color: #0f766e; }
        .environmental-box .item-desc { color: #0d9488; }

        /* Biochemical */
        .biochemical-box {
            background: #fffbeb;
            border-left: 4px solid #f59e0b;
        }
        .biochemical-box .item-name { color: #92400e; }
        .biochemical-box .item-desc { color: #b45309; }

        /* Differential Diagnoses */
        .differential-box {
            background: #fef2f2;
            border-left: 4px solid #dc2626;
        }
        .differential-box .item-name { color: #7f1d1d; }
        .differential-box .item-desc { color: #b91c1c; }

        .differential-similarities {
            background: #fee2e2;
            border-left: 2px solid #dc2626;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-distinctions {
            background: #dcfce7;
            border-left: 2px solid #16a34a;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-similarities strong,
        .differential-distinctions strong {
            display: block;
            margin-bottom: 6px;
            font-size: 0.85rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        .differential-similarities ul,
        .differential-distinctions ul {
            margin-left: 16px;
            line-height: 1.6;
        }

        .differential-similarities li,
        .differential-distinctions li {
            margin: 4px 0;
            font-size: 0.9rem;
        }

        /* Datasets */
        .dataset-box {
            background: #f0f9ff;
            border-left: 4px solid #0284c7;
        }
        .dataset-box .item-name { color: #0c4a6e; }
        .dataset-box .item-desc { color: #0369a1; }

        .tag-dataset {
            background: #e0f2fe;
            color: #0369a1;
        }

        .tag-organism {
            background: #fae8ff;
            color: #a21caf;
        }

        .tag-datatype {
            background: #dbeafe;
            color: #1d4ed8;
        }

        /* Clinical Trials */
        .clinical-trial-box {
            background: #f5f3ff;
            border-left: 4px solid #a855f7;
        }
        .clinical-trial-box .item-name { color: #6b21a8; }
        .clinical-trial-box .item-desc { color: #7e22ce; }

        .tag-phase {
            background: #ede9fe;
            color: #6b21a8;
        }

        .tag-status {
            background: #fce7f3;
            color: #9d174d;
        }

        .trial-nct a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .trial-nct a:hover {
            text-decoration: underline;
        }

        .dataset-accession a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .dataset-accession a:hover {
            text-decoration: underline;
        }

        /* Subtypes */
        .subtype-box {
            background: #eef2ff;
            border-left: 4px solid var(--secondary);
        }
        .subtype-box .item-name { color: #3730a3; }
        .subtype-box .item-desc { color: #4f46e5; }
        .classification-header {
            font-size: 1rem;
            font-weight: 600;
            color: #4338ca;
            margin: 1.2rem 0 0.5rem 0;
            padding-bottom: 0.3rem;
            border-bottom: 2px solid #c7d2fe;
            text-transform: capitalize;
        }
        .subtype-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 0.4rem;
            margin: 0.3rem 0;
        }
        .subtype-freq-badge {
            background: #dbeafe;
            color: #1e40af;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-gene-tag {
            background: #fef3c7;
            color: #92400e;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-inheritance-tag {
            background: #ede9fe;
            color: #5b21b6;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-term-link {
            font-size: 0.8rem;
            color: #6366f1;
            text-decoration: none;
        }
        .subtype-term-link:hover { text-decoration: underline; }
        .subtype-children {
            margin: 0.4rem 0 0.2rem 1rem;
            padding: 0;
            list-style: none;
        }
        .subtype-children li {
            font-size: 0.85rem;
            color: #4338ca;
            padding: 0.1rem 0;
        }
        .subtype-children li::before {
            content: "↳ ";
            color: #a5b4fc;
        }

        /* Stats bar */
        .stats-bar {
            display: flex;
            gap: 24px;
            padding: 20px 24px;
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            margin-bottom: 24px;
            flex-wrap: wrap;
        }

        .stat-item {
            text-align: center;
        }

        .stat-link {
            text-decoration: none;
            color: inherit;
        }

        .stat-value {
            font-size: 1.5rem;
            font-weight: 700;
            color: var(--primary);
        }

        .stat-label {
            font-size: 0.8rem;
            color: var(--text-muted);
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        /* YAML preview */
        .yaml-preview {
            background: #1e293b;
            color: #e2e8f0;
            padding: 20px;
            border-radius: 8px;
            overflow-x: auto;
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            line-height: 1.5;
            max-height: 400px;
            overflow-y: auto;
        }

        .yaml-content {
            display: none;
        }

        .yaml-content.show {
            display: block;
        }

        /* Footer */
        .page-footer {
            margin-top: 40px;
            padding-top: 20px;
            border-top: 1px solid var(--border);
            text-align: center;
            color: var(--text-muted);
            font-size: 0.85rem;
        }

        .page-footer a {
            color: var(--primary);
            text-decoration: none;
        }

        .page-footer a:hover {
            text-decoration: underline;
        }

        /* Responsive */
        @media (max-width: 768px) {
            .page-header h1 { font-size: 1.6rem; }
            .stats-bar { gap: 16px; }
            .section-grid { grid-template-columns: 1fr; }
        }
        /* Mermaid graph */
        .mermaid-container {
            text-align: center;
            margin: 20px 0;
            padding: 20px;
            background: white;
            border-radius: 8px;
            border: 1px solid var(--border);
            overflow-x: auto;
        }

        .mermaid svg {
            max-width: 100%;
            height: auto;
        }

        .graph-warning {
            background: #fef3c7;
            border: 1px solid #f59e0b;
            border-radius: 8px;
            padding: 12px 16px;
            margin-bottom: 16px;
            font-size: 0.85rem;
            color: #92400e;
        }

        .graph-warning strong {
            display: block;
            margin-bottom: 4px;
        }

        .graph-warning ul {
            margin: 8px 0 0 20px;
            padding: 0;
        }

        .graph-warning li {
            margin: 4px 0;
        }
    </style>
    <script src="https://cdn.jsdelivr.net/npm/mermaid@10/dist/mermaid.min.js"></script>
    <script>
        mermaid.initialize({
            startOnLoad: true,
            theme: 'default',
            flowchart: {
                htmlLabels: true,
                curve: 'basis'
            }
        });
    </script>
</head>
<body>
    <div class="notice-banner" role="button" tabindex="0">This resource is in its pre-alpha development stage. Content is actively being curated and may be incomplete or subject to change.</div>
    

    

    
    

    
    

    

    

    

    

    

    <div class="container">
        <nav class="breadcrumb">
            <a href="../../app/index.html">Browse All</a>
            <span> / </span>
            <span>Axenfeld-Rieger_syndrome</span>
        </nav>

        <header class="page-header">
            <h1>Axenfeld-Rieger_syndrome</h1>
            <div class="header-meta">
                
                <span class="badge badge-category">Genetic</span>
                
                
                <span class="badge badge-mondo">
                    <a href="http://purl.obolibrary.org/obo/MONDO_0019187" target="_blank">
                        MONDO:0019187
                    </a>
                </span>
                
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Congenital Eye Disorder</span>
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Craniofacial Disorder</span>
                
            </div>
            
        </header>

        <!-- Stats bar -->
        
        
        
        
        
        
        
        
        
        
        
        
        
        <div class="stats-bar">
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Mappings</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Definitions</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Inheritance</div>
            </div>
            
            
            <a class="stat-link" href="#pathophysiology">
            <div class="stat-item">
                <div class="stat-value">5</div>
                <div class="stat-label">Mechanisms</div>
            </div>
            </a>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Histopathology</div>
            </div>
            
            
            <a class="stat-link" href="#phenotypes">
            <div class="stat-item">
                <div class="stat-value">9</div>
                <div class="stat-label">Phenotypes</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#genetic">
            <div class="stat-item">
                <div class="stat-value">2</div>
                <div class="stat-label">Genes</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#treatments">
            <div class="stat-item">
                <div class="stat-value">4</div>
                <div class="stat-label">Treatments</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#subtypes">
            <div class="stat-item">
                <div class="stat-value">2</div>
                <div class="stat-label">Subtypes</div>
            </div>
            </a>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Differentials</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Datasets</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Trials</div>
            </div>
            
        </div>

        <!-- Classifications -->
        

        <!-- Mappings -->
        

        <!-- Definitions -->
        

        <!-- Inheritance -->
        

        <!-- Subtypes -->
        
        <div class="card" id="subtypes">
            <div class="card-header">
                <div class="card-icon" style="background: #eef2ff; color: #4f46e5;">◆</div>
                <h2 class="card-title">Subtypes</h2>
                <span class="card-count">2</span>
            </div>
            
            
            
                
                
                    
                
                
            
                
                
                
            
            
                
                
                <div class="item-box subtype-box">
                    <div class="item-name">
                        Axenfeld-Rieger Syndrome Type 1 (RIEG1)
                        
                    </div>
                    <div class="subtype-meta">
                        
                        
                        
                    </div>
                    
                    <div class="item-desc">Caused by mutations in the PITX2 gene, characterized by ocular abnormalities and extra-ocular symptoms.</div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/22199394" target="_blank">PMID:22199394</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Recent advances in molecular genetics have identified two major genes, PITX2 and FOXC1, demonstrating a wide spectrum of mutations, which aids in the molecular diagnosis of the disease."</div>
                
                
                <div class="evidence-explanation">The literature confirms that Axenfeld-Rieger syndrome is associated with mutations in the PITX2 gene and is characterized by ocular abnormalities and extra-ocular symptoms.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/31341655" target="_blank">PMID:31341655</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The PITX2 gene may be responsible for a significant portion of ARS with additional systemic defects in the Chinese population."</div>
                
                
                <div class="evidence-explanation">This reference supports the statement by indicating that mutations in the PITX2 gene are linked to Axenfeld-Rieger syndrome, which includes ocular and systemic manifestations.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/11092457" target="_blank">PMID:11092457</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Rieger syndrome (RIEG 1; MIM 180500) is an autosomal dominant disorder of morphogenesis. It is a phenotypically heterogeneous disorder characterized by malformations of the eyes, teeth, and umbilicus."</div>
                
                
                <div class="evidence-explanation">This reference confirms that Rieger syndrome, also known as Axenfeld-Rieger Syndrome Type 1 (RIEG1), involves ocular and extra-ocular abnormalities.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                </div>
                
                <div class="item-box subtype-box">
                    <div class="item-name">
                        Axenfeld-Rieger Syndrome Type 3 (RIEG3)
                        
                    </div>
                    <div class="subtype-meta">
                        
                        
                        
                    </div>
                    
                    <div class="item-desc">Caused by mutations in the FOXC1 gene, associated with similar phenotypic features as Type 1.</div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32741584" target="_blank">PMID:32741584</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Axenfeld-Rieger syndrome (ARS) type 3 is a rare autosomal dominant disease, characterized by anterior segment dysgenesis of the eye, hearing loss, and cardiac defects. ARS type 3 is highly associated with FOXC1 mutations, which induces developmental disorders of neural crest cells."</div>
                
                
                <div class="evidence-explanation">This reference directly supports the statement that Axenfeld-Rieger Syndrome Type 3 (RIEG3) is caused by mutations in the FOXC1 gene and has similar phenotypic features.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                </div>
                
            
        </div>
        

        <!-- Comorbidities -->
        

        <!-- Pathophysiology -->
        
        <div class="card" id="pathophysiology">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">⚙</div>
                <h2 class="card-title">Pathophysiology</h2>
                <span class="card-count">5</span>
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Disrupted Neural Crest-Derived Periocular Mesenchyme Development</div>
                
                <div class="item-desc">PITX2 and FOXC1 haploinsufficiency in cranial neural crest-derived periocular mesenchyme disrupts signaling integration (retinoic acid-PITX2-DKK2 pathway, Hippo/YAP-TAZ-FOXC1 axis, TGF-beta/ECM interactions) leading to failure of normal regression of transient mesenchyme at the iridocorneal angle and maldevelopment of trabecular meshwork and Schlemm&#39;s canal.</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        migratory neural crest cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000333" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        neural crest cell migration
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0001755" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-bio">
                        eye morphogenesis
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0048592" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-bio">
                        canonical Wnt signaling pathway
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0060070" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-location">
                        trabecular meshwork
                        
                        <a href="http://purl.obolibrary.org/obo/UBERON_0001810" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                    <span class="tag tag-location">
                        corneal endothelium
                        
                        <a href="http://purl.obolibrary.org/obo/UBERON_0001772" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                    <span class="tag tag-location">
                        iris stroma
                        
                        <a href="http://purl.obolibrary.org/obo/UBERON_0011821" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/22199394" target="_blank">PMID:22199394</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Recent advances in molecular genetics have identified two major genes, PITX2 and FOXC1, demonstrating a wide spectrum of mutations, which aids in the molecular diagnosis of the disease."</div>
                
                
                <div class="evidence-explanation">Confirms PITX2 and FOXC1 as the primary genes involved in ARS pathogenesis.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Dysregulated Transcription Factor Activity</div>
                
                <div class="item-desc">Mutations in the PITX2 gene disrupt its function as a transcription factor, impairing its ability to bind DNA and regulate gene expression critical for eye development. Most mutations cause defects in DNA binding or transcriptional activation, while some increase transactivation activity, leading to unregulated gene expression during embryogenesis.</div>
                
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        regulation of transcription by RNA polymerase II
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0006357" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-bio">
                        extracellular matrix organization
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0030198" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/19218601" target="_blank">PMID:19218601</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Two homeobox mutations, R43W and R90C, resulted in severely reduced DNA-binding and transcriptional activation despite normal nuclear localization."</div>
                
                
                <div class="evidence-explanation">The reference indicates that some mutations in PITX2 result in reduced DNA-binding and transcriptional activation, which aligns with the statement that mutations disrupt its function.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/15509533" target="_blank">PMID:15509533</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"It has been reported that some mutations in PITX2 increase transactivation, whereas most mutations cause defects in DNA binding or transactivation."</div>
                
                
                <div class="evidence-explanation">This reference supports the statement that mutations in PITX2 can disrupt its function, and mentions that some mutations can increase transactivation activity.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/12130547" target="_blank">PMID:12130547</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The five mutants appeared to be transcriptionally defective despite conserved DNA-binding in CV1 cells."</div>
                
                
                <div class="evidence-explanation">This reference supports the idea that PITX2 mutations can impair its ability to regulate gene expression.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Ocular Anomalies</div>
                
                <div class="item-desc">Improper development of the anterior segment of the eye, leading to issues such as iris defects and abnormal angle structures.</div>
                
                
                
                
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36926528" target="_blank">PMID:36926528</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Axenfeld-Rieger syndrome (ARS) is a rare congenital disease that is primarily characterized by ocular anterior segment anomalies but is also associated with craniofacial, dental, cardiac, and neurologic abnormalities."</div>
                
                
                <div class="evidence-explanation">The literature states that ARS is characterized by ocular anterior segment anomalies, supporting the statement that it involves improper development of the anterior segment of the eye.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/12015278" target="_blank">PMID:12015278</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Individuals with malformations of structures of the anterior segment of the eye frequently develop elevated intraocular pressure and glaucoma."</div>
                
                
                <div class="evidence-explanation">The reference confirms that malformations of the anterior segment of the eye are associated with conditions like glaucoma, supporting the statement about improper development and associated issues.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/35327965" target="_blank">PMID:35327965</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Anterior segment dysgenesis (ASD) encompasses a wide spectrum of developmental abnormalities of the anterior ocular segment, including congenital cataract, iris hypoplasia, aniridia, iridocorneal synechiae, as well as Peters, Axenfeld, and Rieger anomalies."</div>
                
                
                <div class="evidence-explanation">The literature describes Axenfeld and Rieger anomalies as part of anterior segment dysgenesis, which includes iris defects and abnormal angle structures, supporting the statement.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Systemic Anomalies</div>
                
                <div class="item-desc">Involves multiple systems, often including dental, craniofacial, and umbilical abnormalities.</div>
                
                
                
                
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/16302606" target="_blank">PMID:16302606</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Axenfeld-Rieger syndrome is a rare autosomal dominant disorder characterized by various ocular and extraocular malformations. Dental abnormalities are considered as definitive features for the diagnosis and differentiation of Rieger syndrome from other anterior chamber of the eye malformations."</div>
                
                
                <div class="evidence-explanation">The literature describes Axenfeld-Rieger syndrome as involving multiple systems, including dental and craniofacial abnormalities, which supports the statement.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36543336" target="_blank">PMID:36543336</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Axenfeld-Rieger syndrome is a rare multi-system disorder associated with cardiac anomalies."</div>
                
                
                <div class="evidence-explanation">The reference confirms that Axenfeld-Rieger syndrome is a multi-system disorder, which aligns with the statement that it involves multiple systems.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/18599376" target="_blank">PMID:18599376</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"We will consider successively syndromic forms of amelogenesis imperfecta or enamel defects, dentinogenesis imperfecta (i.e. osteogenesis imperfecta) and other dentine anomalies."</div>
                
                
                <div class="evidence-explanation">The literature mentions dental anomalies as significant features in various syndromes, including Axenfeld-Rieger syndrome, supporting the statement.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Glaucoma-related Vision Loss</div>
                
                <div class="item-desc">Loss of vision due to uncontrolled intraocular pressure.</div>
                
                
                
                
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/35733478" target="_blank">PMID:35733478</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Treatment is predominantly the management of glaucoma and is mostly medical but can be surgical in refractory cases."</div>
                
                
                <div class="evidence-explanation">The reference discusses the management of glaucoma in Axenfeld-Rieger syndrome, indicating that loss of vision due to uncontrolled intraocular pressure is a concern.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/33367186" target="_blank">PMID:33367186</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Glaucoma is the main cause of visual morbidity in patients with ARS."</div>
                
                
                <div class="evidence-explanation">The reference explicitly states that glaucoma is the main cause of visual morbidity in Axenfeld-Rieger syndrome, supporting the statement.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28549150" target="_blank">PMID:28549150</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Other early-onset glaucomas may arise secondary to developmental abnormalities, such as glaucomas that occur with aniridia or as part of Axenfeld-Rieger syndrome."</div>
                
                
                <div class="evidence-explanation">The reference mentions that glaucomas associated with Axenfeld-Rieger syndrome can lead to visual disability, supporting the statement.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Histopathology -->
        

        <!-- Causal Graph -->
        

        <!-- Phenotypes -->
        
        <div class="card" id="phenotypes">
            <div class="card-header">
                <div class="card-icon" style="background: #dcfce7; color: #16a34a;">●</div>
                <h2 class="card-title">Phenotypes</h2>
                <span class="card-count">9</span>
            </div>
            
            
            <div class="pheno-toc">
                
                <a class="pheno-toc-pill" data-target="pheno-cat-1">Cardiovascular<span class="pill-count">(1)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-2">Ear<span class="pill-count">(1)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-3">Eye<span class="pill-count">(3)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-4">Head and Neck<span class="pill-count">(1)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-5">Other<span class="pill-count">(3)</span></a>
                
                <button class="pheno-toggle-all" id="phenoToggleAll">Expand all</button>
            </div>
            
            
            <details class="phenotype-category-group" id="pheno-cat-1">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Cardiovascular
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Congenital Heart Defects
                        
                        <span class="phenotype-freq">OCCASIONAL</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0001627" target="_blank">
                                Abnormal heart morphology
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0001627)</span>
                        </span>
                        
                    </div>
                    
                    <div class="item-desc">Cardiac anomalies including endocardial cushion defects and other structural heart malformations. More prevalent in FOXC1-related cases.</div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32741584" target="_blank">PMID:32741584</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Axenfeld-Rieger syndrome (ARS) type 3 is a rare autosomal dominant disease, characterized by anterior segment dysgenesis of the eye, hearing loss, and cardiac defects."</div>
                
                
                <div class="evidence-explanation">This reference confirms cardiac defects are associated with ARS type 3 (FOXC1-related).</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36543336" target="_blank">PMID:36543336</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Axenfeld-Rieger syndrome is a rare multi-system disorder associated with cardiac anomalies."</div>
                
                
                <div class="evidence-explanation">The reference confirms that cardiac anomalies are part of the multi-system presentation of Axenfeld-Rieger syndrome.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-2">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Ear
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Hearing Loss
                        
                        <span class="phenotype-freq">OCCASIONAL</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0000365" target="_blank">
                                Hearing impairment
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0000365)</span>
                        </span>
                        
                    </div>
                    
                    <div class="item-desc">Sensorineural hearing loss observed in some patients, particularly those with FOXC1 variants.</div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/27070436" target="_blank">PMID:27070436</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Key clinical features comprise facial dysmorphism including mid-face and dental hypoplasia, hearing loss, cardiac anomalies, and involuted periumbilical skin."</div>
                
                
                <div class="evidence-explanation">The literature mentions hearing loss as a clinical feature of Axenfeld-Rieger syndrome.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32741584" target="_blank">PMID:32741584</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Axenfeld-Rieger syndrome (ARS) type 3 is a rare autosomal dominant disease, characterized by anterior segment dysgenesis of the eye, hearing loss, and cardiac defects."</div>
                
                
                <div class="evidence-explanation">This reference confirms hearing loss is associated with ARS type 3 (FOXC1-related).</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-3">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Eye
                    <span class="cat-count">3</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Glaucoma
                        
                        <span class="phenotype-freq">VERY_FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0000501" target="_blank">
                                Glaucoma
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0000501)</span>
                        </span>
                        
                    </div>
                    
                    <div class="item-desc">Early onset, often leading to vision loss if untreated. Abnormal development of the anterior segment due to defective PITX2 function leads to poor aqueous humor drainage, resulting in elevated intraocular pressure and glaucoma.</div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (7 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/22199394" target="_blank">PMID:22199394</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"In the eye, this condition manifests with varying degrees of anterior segment dysgenesis and carries a high risk of glaucoma."</div>
                
                
                <div class="evidence-explanation">The literature states that Axenfeld-Rieger syndrome carries a high risk of glaucoma, supporting the statement.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/12015278" target="_blank">PMID:12015278</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Individuals with malformations of structures of the anterior segment of the eye frequently develop elevated intraocular pressure and glaucoma."</div>
                
                
                <div class="evidence-explanation">The literature confirms that malformations of the anterior segment, which are characteristic of Axenfeld-Rieger syndrome, frequently lead to glaucoma.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/27055677" target="_blank">PMID:27055677</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"To determine the long-term surgical and visual outcomes in Indian children with early-onset glaucoma associated with Axenfeld-Rieger anomaly (ARA)."</div>
                
                
                <div class="evidence-explanation">The study specifically investigates early-onset glaucoma associated with Axenfeld-Rieger anomaly, supporting the statement.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 4 more references</div>
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Posterior Embryotoxon
                        
                        <span class="phenotype-freq">VERY_FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0000627" target="_blank">
                                Posterior embryotoxon
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0000627)</span>
                        </span>
                        
                    </div>
                    
                    <div class="item-desc">A prominent, anteriorly displaced Schwalbe&#39;s line seen on eye examination.</div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/15492748" target="_blank">PMID:15492748</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"One of the main ocular features associated with Axenfeld-Rieger is posterior embryotoxon, which is a prominent anteriorly displaced Schwalbe&#39;s line. This can be found in up to 15% of normal eyes, without any clinical significance or may represent a forme fruste of an anterior segment dysgenesis."</div>
                
                
                <div class="evidence-explanation">The literature supports that posterior embryotoxon is a common feature of Axenfeld-Rieger syndrome but does not confirm it as &#39;VERY_FREQUENT&#39;. Additionally, it may be present without clinical significance.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/21666320" target="_blank">PMID:21666320</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The patient had megalocornea with Haab&#39;s striae in the right eye and posterior embryotoxon in both the eyes."</div>
                
                
                <div class="evidence-explanation">The case report supports the presence of posterior embryotoxon in Axenfeld-Rieger syndrome.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/34937757" target="_blank">PMID:34937757</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Posterior embryotoxon, an anteriorly displaced Schwalbe&#39;s line, is the most common feature of Axenfeld Rieger syndrome."</div>
                
                
                <div class="evidence-explanation">This reference confirms that posterior embryotoxon is a common feature of Axenfeld-Rieger syndrome.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Craniofacial Dysmorphism
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0000316" target="_blank">
                                Hypertelorism
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0000316)</span>
                        </span>
                        
                    </div>
                    
                    <div class="item-desc">Includes features such as an underdeveloped maxilla, broad nasal bridge, and hypertelorism (increased distance between the eyes). Hypertelorism is significantly more prevalent in FOXC1 variants (81.8%) compared to PITX2 variants (25.0%).</div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/16302606" target="_blank">PMID:16302606</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Axenfeld-Rieger syndrome is a rare autosomal dominant disorder characterized by various ocular and extraocular malformations. ... Significant cranio-dento-facial findings that have been observed are, teeth with short and dilacerated roots, hyperplastic frenums and underdeveloped maxilla."</div>
                
                
                <div class="evidence-explanation">The literature confirms that craniofacial dysmorphism, including an underdeveloped maxilla, is a feature of Axenfeld-Rieger syndrome.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/33231930" target="_blank">PMID:33231930</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Axenfeld-Rieger syndrome is a genetic condition characterized by ocular and systemic features. ... A thin upper lip (55.9%) and a prominent forehead (41.2%) were common facial features shared between both genes. Hypertelorism/telecanthus (81.8% vs 25.0%, p = 0.002) and low-set ears (31.8% vs..."</div>
                
                
                <div class="evidence-explanation">The literature indicates that hypertelorism, a craniofacial feature, is frequently observed in individuals with Axenfeld-Rieger syndrome.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-4">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Head and Neck
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Dental Anomalies
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0006482" target="_blank">
                                Abnormal dental morphology
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0006482)</span>
                        </span>
                        
                    </div>
                    
                    <div class="item-desc">Includes missing teeth (hypodontia), small teeth (microdontia), and enamel hypoplasia. Highly penetrant in PITX2-related cases.</div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/16302606" target="_blank">PMID:16302606</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Axenfeld-Rieger syndrome is a rare autosomal dominant disorder characterized by various ocular and extraocular malformations. Dental abnormalities are considered as definitive features for the diagnosis and differentiation of Rieger syndrome from other anterior chamber of the eye malformations."</div>
                
                
                <div class="evidence-explanation">The abstract confirms dental abnormalities are definitive features of Rieger syndrome.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/35836351" target="_blank">PMID:35836351</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Enamel formation is disturbed in some patients with ARS. Pitx2 knockdown can influence the proliferation and ameloblast differentiation of inner enamel epithelial cells, and PITX2 may regulate cell proliferation via Wnt/beta-catenin signaling pathway."</div>
                
                
                <div class="evidence-explanation">This study provides evidence for enamel hypoplasia in some patients with Axenfeld-Rieger syndrome but does not provide information on the frequency or other dental anomalies such as hypodontia or microdontia.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-5">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Other
                    <span class="cat-count">3</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Iris Hypoplasia
                        
                        <span class="phenotype-freq">VERY_FREQUENT</span>
                        
                        
                    </div>
                    
                    <div class="item-desc">Underdevelopment of the iris, may include corectopia (displacement of the pupil). Mutations like the V45L variant cause reduced DNA-binding with increased transactivation, disrupting iris development due to unregulated gene expression during embryogenesis.</div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/30860739" target="_blank">PMID:30860739</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"This anomaly encompasses posterior embryotoxon, iris hypoplasia, polycoria, and corectopia."</div>
                
                
                <div class="evidence-explanation">The literature clearly states that iris hypoplasia is a component of the Rieger anomaly, which is part of Axenfeld-Rieger syndrome.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/35327965" target="_blank">PMID:35327965</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Anterior segment dysgenesis (ASD) encompasses a wide spectrum of developmental abnormalities of the anterior ocular segment, including congenital cataract, iris hypoplasia, aniridia, iridocorneal synechiae, as well as Peters, Axenfeld, and Rieger anomalies."</div>
                
                
                <div class="evidence-explanation">The literature confirms that iris hypoplasia is a frequent feature of anterior segment dysgenesis, which includes Axenfeld-Rieger anomalies.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/11740218" target="_blank">PMID:11740218</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"In pedigrees 1,2, and 4, younger generations had iris hypoplasia with severe early-onset glaucoma, whereas their parents had posterior embryotoxon without glaucoma."</div>
                
                
                <div class="evidence-explanation">The literature identifies iris hypoplasia as a clinical feature in multiple pedigrees with Axenfeld-Rieger syndrome.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Corectopia
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                    </div>
                    
                    <div class="item-desc">Displacement of the pupil from its normal central position, often observed alongside iris hypoplasia and other anterior segment abnormalities.</div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/30860739" target="_blank">PMID:30860739</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"This anomaly encompasses posterior embryotoxon, iris hypoplasia, polycoria, and corectopia."</div>
                
                
                <div class="evidence-explanation">The literature explicitly lists corectopia as a component of Rieger anomaly in Axenfeld-Rieger syndrome.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Redundant Periumbilical Skin
                        
                        <span class="phenotype-freq">OCCASIONAL</span>
                        
                        
                    </div>
                    
                    <div class="item-desc">Extra fold of skin around the belly button. Often considered a diagnostic feature. Highly penetrant in PITX2-related cases.</div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/27070436" target="_blank">PMID:27070436</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Key clinical features comprise facial dysmorphism including mid-face and dental hypoplasia, hearing loss, cardiac anomalies, and involuted periumbilical skin."</div>
                
                
                <div class="evidence-explanation">The mention of &#39;involuted periumbilical skin&#39; aligns with the statement&#39;s description of &#39;Redundant Periumbilical Skin.&#39;</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <script>
            (function() {
                // TOC pill click: expand target group and scroll to it
                document.querySelectorAll('.pheno-toc-pill').forEach(function(pill) {
                    pill.addEventListener('click', function() {
                        var target = document.getElementById(pill.dataset.target);
                        if (target) {
                            target.open = true;
                            target.scrollIntoView({behavior: 'smooth', block: 'start'});
                        }
                    });
                });
                // Expand/collapse all toggle
                var btn = document.getElementById('phenoToggleAll');
                if (btn) {
                    btn.addEventListener('click', function() {
                        var groups = document.querySelectorAll('.phenotype-category-group');
                        var anyOpen = Array.from(groups).some(function(g) { return g.open; });
                        groups.forEach(function(g) { g.open = !anyOpen; });
                        btn.textContent = anyOpen ? 'Expand all' : 'Collapse all';
                    });
                }
            })();
            </script>
            
        </div>
        

        <!-- Genetic Associations -->
        
        <div class="card" id="genetic">
            <div class="card-header">
                <div class="card-icon" style="background: #dbeafe; color: #2563eb;">🧬</div>
                <h2 class="card-title">Genetic Associations</h2>
                <span class="card-count">2</span>
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    PITX2
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Pathogenic Variants)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28611552" target="_blank">PMID:28611552</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Axenfeld-Rieger syndrome is a rare autosomal dominant condition... A variant of uncertain significance in PITX2 was identified... it is suggested that this variant can be classified as pathogenic."</div>
                
                
                <div class="evidence-explanation">The study identifies a pathogenic variant in PITX2 associated with Axenfeld-Rieger syndrome, which is an autosomal dominant condition.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/37539177" target="_blank">PMID:37539177</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Mutations in the transcription factors FOXC1 or PITX2 are the most well-studied genetic manifestations of this syndrome."</div>
                
                
                <div class="evidence-explanation">The review supports the association of PITX2 pathogenic variants with Axenfeld-Rieger syndrome.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36442680" target="_blank">PMID:36442680</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"PITX2 and FOXC1 are the most common pathogenic genes associated with Axenfeld-Rieger syndrome (ARS)."</div>
                
                
                <div class="evidence-explanation">The study confirms that PITX2 is a common pathogenic gene in Axenfeld-Rieger syndrome, which is autosomal dominant.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    FOXC1
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Pathogenic Variants)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/34809627" target="_blank">PMID:34809627</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Mutations in the Forkhead Box C1 (FOXC1) are known to cause autosomal dominant hereditary Axenfeld-Rieger syndrome..."</div>
                
                
                <div class="evidence-explanation">This reference explicitly states that mutations in FOXC1 cause autosomal dominant Axenfeld-Rieger syndrome.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/37539177" target="_blank">PMID:37539177</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Mutations in the transcription factors FOXC1 or PITX2 are the most well-studied genetic manifestations of this syndrome."</div>
                
                
                <div class="evidence-explanation">This reference confirms the association of FOXC1 with Axenfeld-Rieger syndrome and describes the genetic nature of the condition.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/22009788" target="_blank">PMID:22009788</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Clinical phenotypes of and genetic aberrations in three unrelated Japanese patients with Axenfeld-Rieger anomalies... FOXC1 was apparently deleted in both patients."</div>
                
                
                <div class="evidence-explanation">This reference supports the association of FOXC1 with Axenfeld-Rieger syndrome through genetic analysis.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Treatments -->
        
        <div class="card" id="treatments">
            <div class="card-header">
                <div class="card-icon" style="background: #ede9fe; color: #7c3aed;">💊</div>
                <h2 class="card-title">Treatments</h2>
                <span class="card-count">4</span>
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Glaucoma Pharmacotherapy
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000058" target="_blank">
                            MAXO:0000058
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Topical medications to reduce intraocular pressure, including prostaglandin analogs, beta-blockers, alpha-agonists, and carbonic anhydrase inhibitors. First-line treatment for glaucoma management.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/18929112" target="_blank">PMID:18929112</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Treatment for glaucoma consists of reducing intraocular pressure (IOP) to an acceptable target range to prevent further optic-nerve damage. Currently available treatments include topical drug (single then multidrug combinations) followed, for those patients on maximal tolerated medical therapy..."</div>
                
                
                <div class="evidence-explanation">This reference supports the use of medications as first-line treatment for managing glaucoma in patients.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Glaucoma Surgery
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000004" target="_blank">
                            MAXO:0000004
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Surgical interventions including trabeculectomy, tube shunt procedures, and angle surgery to control intraocular pressure when medical therapy is insufficient. Surgery is frequently required in ARS-associated glaucoma, particularly in FOXC1-related cases with early onset.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32357855" target="_blank">PMID:32357855</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The goal of this study is to compare the effectiveness of various glaucoma surgeries on intraocular pressure (IOP) management in ARS."</div>
                
                
                <div class="evidence-explanation">The study discusses various surgical interventions for managing intraocular pressure in patients with Axenfeld-Rieger syndrome.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/33881269" target="_blank">PMID:33881269</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The article describes a case of 7-year-old child with rare Axenfeld-Rieger syndrome demonstrating the effectiveness and safety of combined laser reconstructive surgeries."</div>
                
                
                <div class="evidence-explanation">The case report supports the use of laser and surgical therapy as part of the management for Axenfeld-Rieger syndrome.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/35733478" target="_blank">PMID:35733478</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Treatment is predominantly the management of glaucoma and is mostly medical but can be surgical in refractory cases."</div>
                
                
                <div class="evidence-explanation">Confirms that surgical management is used for refractory glaucoma cases in ARS.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Dental Management
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000004" target="_blank">
                            MAXO:0000004
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Orthodontic and dental treatments to address dental anomalies including hypodontia, microdontia, and enamel hypoplasia. May include prosthetic reconstruction, dental implants, and orthodontic correction.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/22104715" target="_blank">PMID:22104715</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The patient showed severe hypodontia, microdontia, and short roots. Different treatment options are discussed. Early diagnosis and an interdisciplinary approach are necessary to provide the best short- and long-term treatment plans, as well as treatment and follow-up for individuals with the syndrome."</div>
                
                
                <div class="evidence-explanation">The reference discusses the dental anomalies in Axenfeld-Rieger syndrome and the importance of early diagnosis and interdisciplinary treatment, aligning with the statement about orthodontic and dental treatments to address these anomalies.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/33487449" target="_blank">PMID:33487449</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The management of a Moroccan family with Axenfeld-Rieger syndrome."</div>
                
                
                <div class="evidence-explanation">The reference indicates the management of Axenfeld-Rieger syndrome, which includes addressing dental anomalies, supporting the statement about orthodontic and dental treatments.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Regular Ophthalmic Monitoring
                    
                </div>
                
                <div class="item-desc">Frequent eye exams to monitor intraocular pressure, visual acuity, and anterior segment changes. Essential for early detection and management of glaucoma progression, particularly in pediatric patients.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36926528" target="_blank">PMID:36926528</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"A multi-disciplinary approach including glaucoma specialists and pediatric ophthalmologists produces optimal outcomes as vision is dependent on many factors including glaucoma, refractive error, amblyopia and strabismus."</div>
                
                
                <div class="evidence-explanation">The literature emphasizes the importance of regular ophthalmic monitoring for managing glaucoma and other ocular issues in Axenfeld-Rieger syndrome.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/33367186" target="_blank">PMID:33367186</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Glaucoma is the main cause of visual morbidity in patients with ARS, therefore a complete periodic ophthalmological exam is a priority."</div>
                
                
                <div class="evidence-explanation">This reference emphasizes the critical importance of regular comprehensive ophthalmologic examinations for ARS patients.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Environmental Factors -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #ccfbf1; color: #0d9488;">🌍</div>
                <h2 class="card-title">Environmental Factors</h2>
                <span class="card-count">1</span>
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">Not Applicable</div>
                
                <div class="item-desc">There are no significant environmental factors specifically associated with the onset of Axenfeld-Rieger syndrome.</div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (9 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/29793789" target="_blank">PMID:29793789</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Axenfeld-Rieger syndrome."</div>
                
                
                <div class="evidence-explanation">The provided literature does not discuss any significant environmental factors associated with the onset of Axenfeld-Rieger syndrome.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/15492748" target="_blank">PMID:15492748</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Axenfeld-Rieger Syndrome is a disorder of morphogenesis which is autosomal dominantly inherited."</div>
                
                
                <div class="evidence-explanation">The literature describes Axenfeld-Rieger syndrome as a genetic disorder, with no mention of environmental factors influencing its onset.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/12210347" target="_blank">PMID:12210347</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Axenfeld-Rieger anomaly (ARA) is an autosomal dominant disorder of the anterior chamber of the eye."</div>
                
                
                <div class="evidence-explanation">The literature focuses on genetic factors and does not mention any environmental factors.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 6 more references</div>
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Biochemical Markers -->
        

        <!-- Differential Diagnoses -->
        

        <!-- Datasets -->
        

        <!-- Clinical Trials -->
        

        <!-- YAML Source -->
        <div class="card">
            <div class="card-header" style="cursor: pointer;" onclick="toggleYaml()">
                <div class="card-icon" style="background: #f1f5f9; color: #475569;">{ }</div>
                <h2 class="card-title">Source YAML</h2>
                <span class="card-count" id="yamlToggleText">click to show</span>
            </div>
            <div class="yaml-content" id="yamlContent">
                <pre class="yaml-preview">name: Axenfeld-Rieger_syndrome
category: Genetic
parents:
- Congenital Eye Disorder
- Craniofacial Disorder
has_subtypes:
- name: Axenfeld-Rieger Syndrome Type 1 (RIEG1)
  description: Caused by mutations in the PITX2 gene, characterized by ocular abnormalities
    and extra-ocular symptoms.
  evidence:
  - reference: PMID:22199394
    supports: SUPPORT
    snippet: Recent advances in molecular genetics have identified two major genes,
      PITX2 and FOXC1, demonstrating a wide spectrum of mutations, which aids in the
      molecular diagnosis of the disease.
    explanation: The literature confirms that Axenfeld-Rieger syndrome is associated
      with mutations in the PITX2 gene and is characterized by ocular abnormalities
      and extra-ocular symptoms.
  - reference: PMID:31341655
    supports: SUPPORT
    snippet: The PITX2 gene may be responsible for a significant portion of ARS with
      additional systemic defects in the Chinese population.
    explanation: This reference supports the statement by indicating that mutations
      in the PITX2 gene are linked to Axenfeld-Rieger syndrome, which includes ocular
      and systemic manifestations.
  - reference: PMID:11092457
    supports: SUPPORT
    snippet: Rieger syndrome (RIEG 1; MIM 180500) is an autosomal dominant disorder
      of morphogenesis. It is a phenotypically heterogeneous disorder characterized
      by malformations of the eyes, teeth, and umbilicus.
    explanation: This reference confirms that Rieger syndrome, also known as Axenfeld-Rieger
      Syndrome Type 1 (RIEG1), involves ocular and extra-ocular abnormalities.
- name: Axenfeld-Rieger Syndrome Type 3 (RIEG3)
  description: Caused by mutations in the FOXC1 gene, associated with similar phenotypic
    features as Type 1.
  evidence:
  - reference: PMID:32741584
    supports: SUPPORT
    snippet: Axenfeld-Rieger syndrome (ARS) type 3 is a rare autosomal dominant disease,
      characterized by anterior segment dysgenesis of the eye, hearing loss, and cardiac
      defects. ARS type 3 is highly associated with FOXC1 mutations, which induces
      developmental disorders of neural crest cells.
    explanation: This reference directly supports the statement that Axenfeld-Rieger
      Syndrome Type 3 (RIEG3) is caused by mutations in the FOXC1 gene and has similar
      phenotypic features.
prevalence:
- population: General Population
  percentage: 0.001-0.002
  evidence:
  - reference: PMID:34269512
    supports: NO_EVIDENCE
    snippet: The combined frequencies of autosomal recessive diseases were estimated
      to be 26.39/10,000 (or ~0.26%).
    explanation: The study provides the combined frequencies of autosomal recessive
      diseases but does not specifically mention the prevalence of Axenfeld-Rieger
      syndrome.
  - reference: PMID:33762894
    supports: NO_EVIDENCE
    snippet: Aarskog-Scott syndrome is a genetically and clinically heterogeneous
      rare condition caused by a pathogenic variant in the FGD1 gene.
    explanation: The study focuses on Aarskog-Scott syndrome and does not provide
      information on the prevalence of Axenfeld-Rieger syndrome.
  - reference: PMID:37684520
    supports: NO_EVIDENCE
    snippet: Marfan syndrome (MFS) is an autosomal dominant condition characterized
      by aortic aneurysm, skeletal abnormalities, and lens dislocation, and is caused
      by variants in the FBN1 gene.
    explanation: The study is about Marfan syndrome and does not provide information
      on the prevalence of Axenfeld-Rieger syndrome.
  - reference: PMID:34229749
    supports: NO_EVIDENCE
    snippet: Rhizomelic chondrodysplasia punctata (RCDP) is an inherited ultra-rare
      disease which results in severely impaired physical and mental development.
    explanation: The study focuses on Rhizomelic chondrodysplasia punctata and does
      not provide information on the prevalence of Axenfeld-Rieger syndrome.
  - reference: PMID:29793789
    supports: NO_EVIDENCE
    snippet: Axenfeld-Rieger syndrome.
    explanation: The title indicates the study is about Axenfeld-Rieger syndrome,
      but it does not provide specific prevalence data in the general population.
  - reference: PMID:28513611
    supports: NO_EVIDENCE
    snippet: Variation in FOXC1 and PITX2 is associated with Axenfeld-Rieger syndrome,
      characterised by structural defects of the anterior chamber of the eye and a
      range of systemic features.
    explanation: The study discusses the genetic associations and clinical features
      of Axenfeld-Rieger syndrome but does not provide prevalence data in the general
      population.
  - reference: PMID:36255854
    supports: NO_EVIDENCE
    snippet: The purpose of this study was to compare the corneal endothelial characteristics
      in Axenfeld anomaly (AXA), Rieger anomaly (RGA), and Axenfeld-Rieger anomaly/syndrome
      with age-matched healthy controls.
    explanation: The study focuses on corneal endothelial characteristics in patients
      with Axenfeld-Rieger syndrome and does not provide prevalence data in the general
      population.
  - reference: PMID:32357855
    supports: NO_EVIDENCE
    snippet: The surgical management of glaucoma associated with Axenfeld-Rieger Syndrome
      (ARS) is poorly described in the literature.
    explanation: The study discusses the surgical outcomes of glaucoma associated
      with Axenfeld-Rieger syndrome but does not provide prevalence data in the general
      population.
  - reference: PMID:9618168
    supports: NO_EVIDENCE
    snippet: Axenfeld-Rieger syndrome (ARS) and iridogoniodysgenesis syndrome (IGDS)
      are clinically related autosomal dominant disorders which affect the anterior
      segment of the eye as well as non-ocular structures.
    explanation: The study discusses the genetic and clinical relationship between
      Axenfeld-Rieger syndrome and iridogoniodysgenesis syndrome but does not provide
      prevalence data in the general population.
pathophysiology:
- name: Disrupted Neural Crest-Derived Periocular Mesenchyme Development
  description: PITX2 and FOXC1 haploinsufficiency in cranial neural crest-derived
    periocular mesenchyme disrupts signaling integration (retinoic acid-PITX2-DKK2
    pathway, Hippo/YAP-TAZ-FOXC1 axis, TGF-beta/ECM interactions) leading to failure
    of normal regression of transient mesenchyme at the iridocorneal angle and maldevelopment
    of trabecular meshwork and Schlemm&#39;s canal.
  cell_types:
  - preferred_term: migratory neural crest cell
    term:
      id: CL:0000333
      label: migratory neural crest cell
  biological_processes:
  - preferred_term: neural crest cell migration
    term:
      id: GO:0001755
      label: neural crest cell migration
  - preferred_term: eye morphogenesis
    term:
      id: GO:0048592
      label: eye morphogenesis
  - preferred_term: canonical Wnt signaling pathway
    term:
      id: GO:0060070
      label: canonical Wnt signaling pathway
  locations:
  - preferred_term: trabecular meshwork
    term:
      id: UBERON:0001810
      label: trabecular meshwork
  - preferred_term: corneal endothelium
    term:
      id: UBERON:0001772
      label: corneal endothelium
  - preferred_term: iris stroma
    term:
      id: UBERON:0011821
      label: iris stroma
  evidence:
  - reference: PMID:22199394
    supports: SUPPORT
    snippet: Recent advances in molecular genetics have identified two major genes,
      PITX2 and FOXC1, demonstrating a wide spectrum of mutations, which aids in the
      molecular diagnosis of the disease.
    explanation: Confirms PITX2 and FOXC1 as the primary genes involved in ARS pathogenesis.
- name: Dysregulated Transcription Factor Activity
  description: Mutations in the PITX2 gene disrupt its function as a transcription
    factor, impairing its ability to bind DNA and regulate gene expression critical
    for eye development. Most mutations cause defects in DNA binding or transcriptional
    activation, while some increase transactivation activity, leading to unregulated
    gene expression during embryogenesis.
  biological_processes:
  - preferred_term: regulation of transcription by RNA polymerase II
    term:
      id: GO:0006357
      label: regulation of transcription by RNA polymerase II
  - preferred_term: extracellular matrix organization
    term:
      id: GO:0030198
      label: extracellular matrix organization
  evidence:
  - reference: PMID:19218601
    supports: SUPPORT
    snippet: Two homeobox mutations, R43W and R90C, resulted in severely reduced DNA-binding
      and transcriptional activation despite normal nuclear localization.
    explanation: The reference indicates that some mutations in PITX2 result in reduced
      DNA-binding and transcriptional activation, which aligns with the statement
      that mutations disrupt its function.
  - reference: PMID:15509533
    supports: SUPPORT
    snippet: It has been reported that some mutations in PITX2 increase transactivation,
      whereas most mutations cause defects in DNA binding or transactivation.
    explanation: This reference supports the statement that mutations in PITX2 can
      disrupt its function, and mentions that some mutations can increase transactivation
      activity.
  - reference: PMID:12130547
    supports: SUPPORT
    snippet: The five mutants appeared to be transcriptionally defective despite conserved
      DNA-binding in CV1 cells.
    explanation: This reference supports the idea that PITX2 mutations can impair
      its ability to regulate gene expression.
  - reference: PMID:21837767
    supports: SUPPORT
    snippet: Mutation in either gene caused reduced transcriptional activation to
      different extents on the FOXO1 and PLOD1 promoters.
    explanation: This reference supports the idea that PITX2 mutations can disrupt
      its function as a transcription factor.
- name: Ocular Anomalies
  description: Improper development of the anterior segment of the eye, leading to
    issues such as iris defects and abnormal angle structures.
  evidence:
  - reference: PMID:36926528
    supports: SUPPORT
    snippet: Axenfeld-Rieger syndrome (ARS) is a rare congenital disease that is primarily
      characterized by ocular anterior segment anomalies but is also associated with
      craniofacial, dental, cardiac, and neurologic abnormalities.
    explanation: The literature states that ARS is characterized by ocular anterior
      segment anomalies, supporting the statement that it involves improper development
      of the anterior segment of the eye.
  - reference: PMID:12015278
    supports: SUPPORT
    snippet: Individuals with malformations of structures of the anterior segment
      of the eye frequently develop elevated intraocular pressure and glaucoma.
    explanation: The reference confirms that malformations of the anterior segment
      of the eye are associated with conditions like glaucoma, supporting the statement
      about improper development and associated issues.
  - reference: PMID:35327965
    supports: SUPPORT
    snippet: Anterior segment dysgenesis (ASD) encompasses a wide spectrum of developmental
      abnormalities of the anterior ocular segment, including congenital cataract,
      iris hypoplasia, aniridia, iridocorneal synechiae, as well as Peters, Axenfeld,
      and Rieger anomalies.
    explanation: The literature describes Axenfeld and Rieger anomalies as part of
      anterior segment dysgenesis, which includes iris defects and abnormal angle
      structures, supporting the statement.
  - reference: PMID:31560925
    supports: SUPPORT
    snippet: Aniridia and Axenfeld-Rieger Syndrome are related, human ocular disorders
      that are typically inherited in an autosomal dominant manner. Both result from
      incorrect development of the eye and have, as their most serious consequences,
      elevated risk to develop the blinding condition glaucoma.
    explanation: The literature confirms that Axenfeld-Rieger Syndrome results from
      incorrect development of the eye, specifically mentioning the anterior segment,
      supporting the statement.
- name: Systemic Anomalies
  description: Involves multiple systems, often including dental, craniofacial, and
    umbilical abnormalities.
  evidence:
  - reference: PMID:16302606
    supports: SUPPORT
    snippet: Axenfeld-Rieger syndrome is a rare autosomal dominant disorder characterized
      by various ocular and extraocular malformations. Dental abnormalities are considered
      as definitive features for the diagnosis and differentiation of Rieger syndrome
      from other anterior chamber of the eye malformations.
    explanation: The literature describes Axenfeld-Rieger syndrome as involving multiple
      systems, including dental and craniofacial abnormalities, which supports the
      statement.
  - reference: PMID:36543336
    supports: SUPPORT
    snippet: Axenfeld-Rieger syndrome is a rare multi-system disorder associated with
      cardiac anomalies.
    explanation: The reference confirms that Axenfeld-Rieger syndrome is a multi-system
      disorder, which aligns with the statement that it involves multiple systems.
  - reference: PMID:18599376
    supports: SUPPORT
    snippet: We will consider successively syndromic forms of amelogenesis imperfecta
      or enamel defects, dentinogenesis imperfecta (i.e. osteogenesis imperfecta)
      and other dentine anomalies.
    explanation: The literature mentions dental anomalies as significant features
      in various syndromes, including Axenfeld-Rieger syndrome, supporting the statement.
- name: Glaucoma-related Vision Loss
  frequency: OCCASIONAL
  description: Loss of vision due to uncontrolled intraocular pressure.
  evidence:
  - reference: PMID:35733478
    supports: SUPPORT
    snippet: Treatment is predominantly the management of glaucoma and is mostly medical
      but can be surgical in refractory cases.
    explanation: The reference discusses the management of glaucoma in Axenfeld-Rieger
      syndrome, indicating that loss of vision due to uncontrolled intraocular pressure
      is a concern.
  - reference: PMID:33367186
    supports: SUPPORT
    snippet: Glaucoma is the main cause of visual morbidity in patients with ARS.
    explanation: The reference explicitly states that glaucoma is the main cause of
      visual morbidity in Axenfeld-Rieger syndrome, supporting the statement.
  - reference: PMID:28549150
    supports: SUPPORT
    snippet: Other early-onset glaucomas may arise secondary to developmental abnormalities,
      such as glaucomas that occur with aniridia or as part of Axenfeld-Rieger syndrome.
    explanation: The reference mentions that glaucomas associated with Axenfeld-Rieger
      syndrome can lead to visual disability, supporting the statement.
  - reference: PMID:5467709
    supports: SUPPORT
    snippet: Glaucoma and Rieger&#39;s syndrome.
    explanation: The title suggests a direct relationship between glaucoma and Axenfeld-Rieger
      syndrome, implying that vision loss due to glaucoma is a concern.
phenotypes:
- category: Ophthalmologic
  name: Glaucoma
  frequency: VERY_FREQUENT
  severity: Severe
  diagnostic: true
  notes: Early onset, often leading to vision loss if untreated. Abnormal development
    of the anterior segment due to defective PITX2 function leads to poor aqueous
    humor drainage, resulting in elevated intraocular pressure and glaucoma.
  evidence:
  - reference: PMID:22199394
    supports: SUPPORT
    snippet: In the eye, this condition manifests with varying degrees of anterior
      segment dysgenesis and carries a high risk of glaucoma.
    explanation: The literature states that Axenfeld-Rieger syndrome carries a high
      risk of glaucoma, supporting the statement.
  - reference: PMID:12015278
    supports: SUPPORT
    snippet: Individuals with malformations of structures of the anterior segment
      of the eye frequently develop elevated intraocular pressure and glaucoma.
    explanation: The literature confirms that malformations of the anterior segment,
      which are characteristic of Axenfeld-Rieger syndrome, frequently lead to glaucoma.
  - reference: PMID:27055677
    supports: SUPPORT
    snippet: To determine the long-term surgical and visual outcomes in Indian children
      with early-onset glaucoma associated with Axenfeld-Rieger anomaly (ARA).
    explanation: The study specifically investigates early-onset glaucoma associated
      with Axenfeld-Rieger anomaly, supporting the statement.
  - reference: PMID:32905845
    supports: SUPPORT
    snippet: Our study describes the glaucoma phenotype in a family with Axenfeld-Rieger
      syndrome (ARS) and a FOXC1 variant.
    explanation: The literature describes glaucoma phenotypes in individuals with
      Axenfeld-Rieger syndrome, supporting the statement.
  - reference: PMID:33367186
    supports: SUPPORT
    snippet: Glaucoma is the main cause of visual morbidity in patients with ARS,
      therefore a complete periodic ophthalmological exam is a priority.
    explanation: The literature states that glaucoma is a major cause of visual morbidity
      in Axenfeld-Rieger syndrome, supporting the statement.
  - reference: PMID:21666320
    supports: SUPPORT
    snippet: The patient had megalocornea with Haab&#39;s striae in the right eye and
      posterior embryotoxon in both the eyes. In the left eye, there was a white cord-like
      structure traversing the anterior chamber with adhesions to iris tissue along
      its course.
    explanation: The literature describes ocular abnormalities consistent with glaucoma
      in Axenfeld-Rieger syndrome, supporting the statement.
  - reference: PMID:15509533
    supports: SUPPORT
    snippet: The eye manifests with iris ruptures, irido-corneal adhesions, cloudy
      corneas, and glaucoma.
    explanation: The literature explicitly states that glaucoma is a manifestation
      of Axenfeld-Rieger syndrome, supporting the statement.
  phenotype_term:
    preferred_term: Glaucoma
    term:
      id: HP:0000501
      label: Glaucoma
- category: Ophthalmologic
  name: Posterior Embryotoxon
  frequency: VERY_FREQUENT
  severity: Mild
  diagnostic: true
  notes: A prominent, anteriorly displaced Schwalbe&#39;s line seen on eye examination.
  evidence:
  - reference: PMID:15492748
    supports: PARTIAL
    snippet: One of the main ocular features associated with Axenfeld-Rieger is posterior
      embryotoxon, which is a prominent anteriorly displaced Schwalbe&#39;s line. This
      can be found in up to 15% of normal eyes, without any clinical significance
      or may represent a forme fruste of an anterior segment dysgenesis.
    explanation: The literature supports that posterior embryotoxon is a common feature
      of Axenfeld-Rieger syndrome but does not confirm it as &#39;VERY_FREQUENT&#39;. Additionally,
      it may be present without clinical significance.
  - reference: PMID:21666320
    supports: SUPPORT
    snippet: The patient had megalocornea with Haab&#39;s striae in the right eye and
      posterior embryotoxon in both the eyes.
    explanation: The case report supports the presence of posterior embryotoxon in
      Axenfeld-Rieger syndrome.
  - reference: PMID:34937757
    supports: SUPPORT
    snippet: Posterior embryotoxon, an anteriorly displaced Schwalbe&#39;s line, is the
      most common feature of Axenfeld Rieger syndrome.
    explanation: This reference confirms that posterior embryotoxon is a common feature
      of Axenfeld-Rieger syndrome.
  - reference: PMID:38006999
    supports: SUPPORT
    snippet: Posterior embryotoxon as the initial ophthalmological sign of Axenfeld-Rieger
      syndrome.
    explanation: This reference supports the statement that posterior embryotoxon
      is a diagnostic feature of Axenfeld-Rieger syndrome.
  phenotype_term:
    preferred_term: Posterior Embryotoxon
    term:
      id: HP:0000627
      label: Posterior embryotoxon
- category: Ophthalmologic
  name: Iris Hypoplasia
  frequency: VERY_FREQUENT
  notes: Underdevelopment of the iris, may include corectopia (displacement of the
    pupil). Mutations like the V45L variant cause reduced DNA-binding with increased
    transactivation, disrupting iris development due to unregulated gene expression
    during embryogenesis.
  evidence:
  - reference: PMID:30860739
    supports: SUPPORT
    snippet: This anomaly encompasses posterior embryotoxon, iris hypoplasia, polycoria,
      and corectopia.
    explanation: The literature clearly states that iris hypoplasia is a component
      of the Rieger anomaly, which is part of Axenfeld-Rieger syndrome.
  - reference: PMID:35327965
    supports: SUPPORT
    snippet: Anterior segment dysgenesis (ASD) encompasses a wide spectrum of developmental
      abnormalities of the anterior ocular segment, including congenital cataract,
      iris hypoplasia, aniridia, iridocorneal synechiae, as well as Peters, Axenfeld,
      and Rieger anomalies.
    explanation: The literature confirms that iris hypoplasia is a frequent feature
      of anterior segment dysgenesis, which includes Axenfeld-Rieger anomalies.
  - reference: PMID:11740218
    supports: SUPPORT
    snippet: In pedigrees 1,2, and 4, younger generations had iris hypoplasia with
      severe early-onset glaucoma, whereas their parents had posterior embryotoxon
      without glaucoma.
    explanation: The literature identifies iris hypoplasia as a clinical feature in
      multiple pedigrees with Axenfeld-Rieger syndrome.
- category: Ophthalmologic
  name: Corectopia
  frequency: FREQUENT
  notes: Displacement of the pupil from its normal central position, often observed
    alongside iris hypoplasia and other anterior segment abnormalities.
  evidence:
  - reference: PMID:30860739
    supports: SUPPORT
    snippet: This anomaly encompasses posterior embryotoxon, iris hypoplasia, polycoria,
      and corectopia.
    explanation: The literature explicitly lists corectopia as a component of Rieger
      anomaly in Axenfeld-Rieger syndrome.
- category: Craniofacial
  name: Dental Anomalies
  frequency: FREQUENT
  notes: Includes missing teeth (hypodontia), small teeth (microdontia), and enamel
    hypoplasia. Highly penetrant in PITX2-related cases.
  phenotype_term:
    preferred_term: Abnormal dental morphology
    term:
      id: HP:0006482
      label: Abnormal dental morphology
  evidence:
  - reference: PMID:16302606
    supports: SUPPORT
    snippet: Axenfeld-Rieger syndrome is a rare autosomal dominant disorder characterized
      by various ocular and extraocular malformations. Dental abnormalities are considered
      as definitive features for the diagnosis and differentiation of Rieger syndrome
      from other anterior chamber of the eye malformations.
    explanation: The abstract confirms dental abnormalities are definitive features
      of Rieger syndrome.
  - reference: PMID:35836351
    supports: PARTIAL
    snippet: Enamel formation is disturbed in some patients with ARS. Pitx2 knockdown
      can influence the proliferation and ameloblast differentiation of inner enamel
      epithelial cells, and PITX2 may regulate cell proliferation via Wnt/beta-catenin
      signaling pathway.
    explanation: This study provides evidence for enamel hypoplasia in some patients
      with Axenfeld-Rieger syndrome but does not provide information on the frequency
      or other dental anomalies such as hypodontia or microdontia.
- category: Craniofacial
  name: Craniofacial Dysmorphism
  frequency: FREQUENT
  notes: Includes features such as an underdeveloped maxilla, broad nasal bridge,
    and hypertelorism (increased distance between the eyes). Hypertelorism is significantly
    more prevalent in FOXC1 variants (81.8%) compared to PITX2 variants (25.0%).
  phenotype_term:
    preferred_term: Hypertelorism
    term:
      id: HP:0000316
      label: Hypertelorism
  evidence:
  - reference: PMID:16302606
    supports: SUPPORT
    snippet: Axenfeld-Rieger syndrome is a rare autosomal dominant disorder characterized
      by various ocular and extraocular malformations. ... Significant cranio-dento-facial
      findings that have been observed are, teeth with short and dilacerated roots,
      hyperplastic frenums and underdeveloped maxilla.
    explanation: The literature confirms that craniofacial dysmorphism, including
      an underdeveloped maxilla, is a feature of Axenfeld-Rieger syndrome.
  - reference: PMID:33231930
    supports: SUPPORT
    snippet: Axenfeld-Rieger syndrome is a genetic condition characterized by ocular
      and systemic features. ... A thin upper lip (55.9%) and a prominent forehead
      (41.2%) were common facial features shared between both genes. Hypertelorism/telecanthus
      (81.8% vs 25.0%, p = 0.002) and low-set ears (31.8% vs 0.0%, p = 0.036) were
      significantly more prevalent in individuals with FOXC1 variants compared with
      PITX2 variants.
    explanation: The literature indicates that hypertelorism, a craniofacial feature,
      is frequently observed in individuals with Axenfeld-Rieger syndrome.
- category: Systemic
  name: Redundant Periumbilical Skin
  frequency: OCCASIONAL
  notes: Extra fold of skin around the belly button. Often considered a diagnostic
    feature. Highly penetrant in PITX2-related cases.
  evidence:
  - reference: PMID:27070436
    supports: SUPPORT
    snippet: Key clinical features comprise facial dysmorphism including mid-face
      and dental hypoplasia, hearing loss, cardiac anomalies, and involuted periumbilical
      skin.
    explanation: The mention of &#39;involuted periumbilical skin&#39; aligns with the statement&#39;s
      description of &#39;Redundant Periumbilical Skin.&#39;
- category: Systemic
  name: Hearing Loss
  frequency: OCCASIONAL
  notes: Sensorineural hearing loss observed in some patients, particularly those
    with FOXC1 variants.
  phenotype_term:
    preferred_term: Hearing impairment
    term:
      id: HP:0000365
      label: Hearing impairment
  evidence:
  - reference: PMID:27070436
    supports: SUPPORT
    snippet: Key clinical features comprise facial dysmorphism including mid-face
      and dental hypoplasia, hearing loss, cardiac anomalies, and involuted periumbilical
      skin.
    explanation: The literature mentions hearing loss as a clinical feature of Axenfeld-Rieger
      syndrome.
  - reference: PMID:32741584
    supports: SUPPORT
    snippet: Axenfeld-Rieger syndrome (ARS) type 3 is a rare autosomal dominant disease,
      characterized by anterior segment dysgenesis of the eye, hearing loss, and cardiac
      defects.
    explanation: This reference confirms hearing loss is associated with ARS type
      3 (FOXC1-related).
- category: Systemic
  name: Congenital Heart Defects
  frequency: OCCASIONAL
  notes: Cardiac anomalies including endocardial cushion defects and other structural
    heart malformations. More prevalent in FOXC1-related cases.
  phenotype_term:
    preferred_term: Congenital heart defect
    term:
      id: HP:0001627
      label: Abnormal heart morphology
  evidence:
  - reference: PMID:32741584
    supports: SUPPORT
    snippet: Axenfeld-Rieger syndrome (ARS) type 3 is a rare autosomal dominant disease,
      characterized by anterior segment dysgenesis of the eye, hearing loss, and cardiac
      defects.
    explanation: This reference confirms cardiac defects are associated with ARS type
      3 (FOXC1-related).
  - reference: PMID:36543336
    supports: SUPPORT
    snippet: Axenfeld-Rieger syndrome is a rare multi-system disorder associated with
      cardiac anomalies.
    explanation: The reference confirms that cardiac anomalies are part of the multi-system
      presentation of Axenfeld-Rieger syndrome.
diagnosis:
- name: Genetic Testing
  notes: Identifies mutations in PITX2, FOXC1 or other associated genes.
  evidence:
  - reference: PMID:11821690
    supports: SUPPORT
    snippet: This study examined the two genes known to cause Rieger syndrome, PITX2
      and FOXC1, for mutations in five Brazilian families with Axenfeld-Rieger syndrome.
    explanation: The study confirms that genetic testing identifies mutations in PITX2
      and FOXC1 in patients with Axenfeld-Rieger syndrome.
  - reference: PMID:25893250
    supports: SUPPORT
    snippet: A novel heterozygous PITX2 mutation... was identified in a family with
      endocardial cushion defect (ECD) and Axenfeld-Rieger syndrome (ARS).
    explanation: The study identifies a PITX2 mutation in a family with Axenfeld-Rieger
      syndrome, supporting the statement.
  - reference: PMID:28730073
    supports: SUPPORT
    snippet: Genome-wide linkage and exome sequencing analyses showed PITX2 as the
      disease candidate gene.
    explanation: The study identifies PITX2 as the gene responsible for the disease
      in a Chinese family with Axenfeld-Rieger syndrome.
  - reference: PMID:15654696
    supports: SUPPORT
    snippet: Detailed analysis confirmed deletion of the FOXC1 forkhead gene cluster
      at 6p25.
    explanation: The study confirms the involvement of FOXC1 in Axenfeld-Rieger syndrome.
  - reference: PMID:28611552
    supports: SUPPORT
    snippet: A variant of uncertain significance in PITX2 was identified.
    explanation: The study reports a variant in PITX2 in a patient with Axenfeld-Rieger
      syndrome, supporting the role of genetic testing in identifying mutations in
      this gene.
  - reference: PMID:10713890
    supports: SUPPORT
    snippet: Mutations in the forkhead-like 7 (FKHL7) gene have been recently shown
      to cause juvenile glaucoma and anterior segment anomalies.
    explanation: The study identifies FKHL7 (now known as FOXC1) as a gene associated
      with Axenfeld-Rieger syndrome.
- name: Slit-lamp Examination
  notes: Used to observe anterior segment anomalies such as posterior embryotoxon
    and iris defects.
  evidence:
  - reference: PMID:15492748
    supports: SUPPORT
    snippet: One of the main ocular features associated with Axenfeld-Rieger is posterior
      embryotoxon, which is a prominent anteriorly displaced Schwalbe&#39;s line.
    explanation: The abstract mentions that posterior embryotoxon is a key feature
      observed in Axenfeld-Rieger syndrome, which can be detected using slit-lamp
      examination.
  - reference: PMID:808872
    supports: SUPPORT
    snippet: The peripheral anomalies consist of a prominent Schwalbe&#39;s ring, iris
      strands to Schwalbe&#39;s ring, and hypoplasia of the anterior iris stroma.
    explanation: The study classifies anterior segment anomalies, including posterior
      embryotoxon and iris defects, which can be observed using slit-lamp examination.
  - reference: PMID:36255854
    supports: SUPPORT
    snippet: Patients with AXA, RGA, and Axenfeld-Rieger anomaly/syndrome have lower
      ECD and increased MCA compared with normal eyes.
    explanation: The study discusses various features of Axenfeld-Rieger syndrome,
      including anterior segment anomalies that can be observed via slit-lamp examination.
  - reference: PMID:33367186
    supports: SUPPORT
    snippet: In the biomicroscopy, a posterior embryotoxon, iris atrophy with absence
      of crypts and irregularity of pigmentation, and discoria in OU were observed.
    explanation: The case report describes the use of slit-lamp examination to observe
      posterior embryotoxon and iris defects in a patient with Axenfeld-Rieger syndrome.
- name: Intraocular Pressure Measurement
  notes: Elevated pressure indicating glaucoma, which is common in these patients.
  evidence:
  - reference: PMID:33367186
    supports: SUPPORT
    snippet: Glaucoma is the main cause of visual morbidity in patients with ARS,
      therefore a complete periodic ophthalmological exam is a priority.
    explanation: The literature confirms that glaucoma, which is associated with elevated
      intraocular pressure, is a common issue in patients with Axenfeld-Rieger Syndrome
      (ARS).
  - reference: PMID:5467709
    supports: SUPPORT
    snippet: Glaucoma and Rieger&#39;s syndrome.
    explanation: The title of the reference directly links glaucoma, which involves
      elevated intraocular pressure, with Rieger&#39;s syndrome (a component of Axenfeld-Rieger
      Syndrome).
genetic:
- name: PITX2
  association: Pathogenic Variants
  subtype: Autosomal Dominant
  notes: Paired-like homeodomain transcription factor critical for periocular mesenchyme
    differentiation and anterior segment development. Regulates WNT signaling through
    DKK2 induction and controls ECM/collagen gene expression. Associated with ARS
    Type 1 (RIEG1).
  evidence:
  - reference: PMID:28611552
    supports: SUPPORT
    snippet: Axenfeld-Rieger syndrome is a rare autosomal dominant condition... A
      variant of uncertain significance in PITX2 was identified... it is suggested
      that this variant can be classified as pathogenic.
    explanation: The study identifies a pathogenic variant in PITX2 associated with
      Axenfeld-Rieger syndrome, which is an autosomal dominant condition.
  - reference: PMID:37539177
    supports: SUPPORT
    snippet: Mutations in the transcription factors FOXC1 or PITX2 are the most well-studied
      genetic manifestations of this syndrome.
    explanation: The review supports the association of PITX2 pathogenic variants
      with Axenfeld-Rieger syndrome.
  - reference: PMID:36442680
    supports: SUPPORT
    snippet: PITX2 and FOXC1 are the most common pathogenic genes associated with
      Axenfeld-Rieger syndrome (ARS).
    explanation: The study confirms that PITX2 is a common pathogenic gene in Axenfeld-Rieger
      syndrome, which is autosomal dominant.
  - reference: PMID:9685346
    supports: SUPPORT
    snippet: Mutations in the Pitx2 homeobox gene have been linked to Rieger syndrome.
    explanation: The study identifies PITX2 mutations as linked to Rieger syndrome,
      which is a part of the Axenfeld-Rieger syndrome spectrum.
- name: FOXC1
  association: Pathogenic Variants
  subtype: Autosomal Dominant
  notes: Forkhead transcription factor with dosage-sensitive regulation of neural
    crest derivatives, trabecular meshwork development, and ocular/endothelial programs.
    Controls CD98-mTOR axis in retinal angiogenesis. Associated with ARS Type 3 (RIEG3)
    and earlier glaucoma onset compared to PITX2 variants.
  evidence:
  - reference: PMID:34809627
    supports: SUPPORT
    snippet: Mutations in the Forkhead Box C1 (FOXC1) are known to cause autosomal
      dominant hereditary Axenfeld-Rieger syndrome...
    explanation: This reference explicitly states that mutations in FOXC1 cause autosomal
      dominant Axenfeld-Rieger syndrome.
  - reference: PMID:37539177
    supports: SUPPORT
    snippet: Mutations in the transcription factors FOXC1 or PITX2 are the most well-studied
      genetic manifestations of this syndrome.
    explanation: This reference confirms the association of FOXC1 with Axenfeld-Rieger
      syndrome and describes the genetic nature of the condition.
  - reference: PMID:22009788
    supports: SUPPORT
    snippet: Clinical phenotypes of and genetic aberrations in three unrelated Japanese
      patients with Axenfeld-Rieger anomalies... FOXC1 was apparently deleted in both
      patients.
    explanation: This reference supports the association of FOXC1 with Axenfeld-Rieger
      syndrome through genetic analysis.
  - reference: PMID:33530637
    supports: SUPPORT
    snippet: Mutations of one cascade constituent PITX2 and, separately, the Forkhead
      transcription factor FOXC1 independently cause a multi-system disorder known
      as Axenfeld-Rieger syndrome (ARS).
    explanation: This reference supports the statement by identifying FOXC1 mutations
      as a cause of Axenfeld-Rieger syndrome.
variants:
- name: p.Val136Leu
  gene:
    preferred_term: PITX2
  clinical_significance: PATHOGENIC
  type: single_nucleotide_variant
  sequence_length: 1
  synonyms:
  - V45L
  identifiers:
  - OMIM:601542.0010
  - dbSNP:rs121909249
  functional_effects:
  - function: DNA binding
    description: tenfold reduction
    type: loss-of-function
  - function: DNA-binding transcription factor activity
    description: increases 200%
  evidence:
  - reference: PMID:19218601
    supports: NO_EVIDENCE
    snippet: Two homeobox mutations, R43W and R90C, resulted in severely reduced DNA-binding
      and transcriptional activation despite normal nuclear localization. L105V, located
      C-terminal to the homeodomain, resulted in normal localization, reporter gene
      transactivation, and protein half-life, but with an altered mobility shift pattern
      of protein-DNA complexes. N108T, also located C-terminal to the homeodomain,
      resulted in an altered mobility shift pattern and with slightly increased reporter
      transactivation and shortened protein half-life.
    explanation: This study does not mention the p.Val136Leu (V45L) variant. It discusses
      other PITX2 mutations but does not provide evidence for the specific variant
      mentioned in the statement.
  - reference: PMID:28611552
    supports: NO_EVIDENCE
    snippet: The mutation, NM_153427.2:c.272G&gt;A (p.Arg91Gln), is predicted to be damaging
      by PolyPhen-2 (score of 0.997), identified as a missense mutation with an allele
      frequency of 1.648e-05 by the Exome Aggregation Consortium, and has been reported
      in ClinVar once, by the laboratory that analyzed our patient&#39;s sample.
    explanation: This study discusses a different PITX2 mutation (p.Arg91Gln) and
      does not provide evidence for the p.Val136Leu (V45L) variant.
  - reference: PMID:9685346
    supports: NO_EVIDENCE
    snippet: We next studied two Rieger mutants. A threonine to proline mutation (T68P)
      in the second helix of the homeodomain retained DNA binding activity with the
      same apparent KD and only about a 2-fold reduction in the Bmax. However, this
      mutant did not transactivate reporter genes containing the bicoid site.
    explanation: This study investigates different PITX2 mutations (T68P and L54Q)
      and does not provide evidence for the p.Val136Leu (V45L) variant.
environmental:
- name: Not Applicable
  notes: There are no significant environmental factors specifically associated with
    the onset of Axenfeld-Rieger syndrome.
  evidence:
  - reference: PMID:29793789
    supports: NO_EVIDENCE
    snippet: Axenfeld-Rieger syndrome.
    explanation: The provided literature does not discuss any significant environmental
      factors associated with the onset of Axenfeld-Rieger syndrome.
  - reference: PMID:15492748
    supports: NO_EVIDENCE
    snippet: Axenfeld-Rieger Syndrome is a disorder of morphogenesis which is autosomal
      dominantly inherited.
    explanation: The literature describes Axenfeld-Rieger syndrome as a genetic disorder,
      with no mention of environmental factors influencing its onset.
  - reference: PMID:12210347
    supports: NO_EVIDENCE
    snippet: Axenfeld-Rieger anomaly (ARA) is an autosomal dominant disorder of the
      anterior chamber of the eye.
    explanation: The literature focuses on genetic factors and does not mention any
      environmental factors.
  - reference: PMID:3104560
    supports: NO_EVIDENCE
    snippet: Apart from the three distinguishing findings for the diagnosis of Axenfeld-Rieger
      syndrome (oligodontia, failure of periumbilical skin to involute, and ocular
      anterior chamber defects)...
    explanation: The literature discusses clinical and genetic aspects of Axenfeld-Rieger
      syndrome, without mentioning environmental factors.
  - reference: PMID:37822332
    supports: NO_EVIDENCE
    snippet: Genetic analysis confirmed heterozygous pathogenic variants in both the
      FOXC1 and COL2A1 genes, leading to the concurrent diagnoses of Axenfeld-Rieger
      and Stickler syndromes.
    explanation: The literature emphasizes genetic mutations as the cause of Axenfeld-Rieger
      syndrome.
  - reference: PMID:12381896
    supports: NO_EVIDENCE
    snippet: Mutational screening and sequence analysis of the PITX2 gene was performed
      in four families previously diagnosed with Rieger syndrome.
    explanation: The literature focuses on genetic mutations in the PITX2 gene and
      does not discuss environmental factors.
  - reference: PMID:32045938
    supports: NO_EVIDENCE
    snippet: We report on two adolescent individuals with ocular anterior segment
      dysgenesis (Axenfeld-Rieger anomaly) presenting with neuropsychiatric symptoms.
    explanation: The literature discusses genetic mutations and associated neuropsychiatric
      symptoms, with no mention of environmental factors.
  - reference: PMID:11004268
    supports: NO_EVIDENCE
    snippet: Axenfeld-Rieger syndrome is a term that can be used to describe a variety
      of overlapping phenotypes. To date, at least three known genetic loci can cause
      these disorders.
    explanation: The literature reviews genetic loci associated with Axenfeld-Rieger
      syndrome and does not mention environmental factors.
  - reference: PMID:26281856
    supports: NO_EVIDENCE
    snippet: Axenfeld-Rieger syndrome (ARS) is a rare autosomal dominant condition
      manifesting as a heterogeneous group of features.
    explanation: The literature describes Axenfeld-Rieger syndrome as a genetic condition,
      with no mention of environmental factors.
treatments:
- name: Glaucoma Pharmacotherapy
  description: Topical medications to reduce intraocular pressure, including prostaglandin
    analogs, beta-blockers, alpha-agonists, and carbonic anhydrase inhibitors. First-line
    treatment for glaucoma management.
  treatment_term:
    preferred_term: pharmacotherapy
    term:
      id: MAXO:0000058
      label: pharmacotherapy
  evidence:
  - reference: PMID:18929112
    supports: SUPPORT
    snippet: Treatment for glaucoma consists of reducing intraocular pressure (IOP)
      to an acceptable target range to prevent further optic-nerve damage. Currently
      available treatments include topical drug (single then multidrug combinations)
      followed, for those patients on maximal tolerated medical therapy who still
      need additional IOP reduction, by laser treatments.
    explanation: This reference supports the use of medications as first-line treatment
      for managing glaucoma in patients.
- name: Glaucoma Surgery
  description: Surgical interventions including trabeculectomy, tube shunt procedures,
    and angle surgery to control intraocular pressure when medical therapy is insufficient.
    Surgery is frequently required in ARS-associated glaucoma, particularly in FOXC1-related
    cases with early onset.
  treatment_term:
    preferred_term: surgical procedure
    term:
      id: MAXO:0000004
      label: surgical procedure
  evidence:
  - reference: PMID:32357855
    supports: SUPPORT
    snippet: The goal of this study is to compare the effectiveness of various glaucoma
      surgeries on intraocular pressure (IOP) management in ARS.
    explanation: The study discusses various surgical interventions for managing intraocular
      pressure in patients with Axenfeld-Rieger syndrome.
  - reference: PMID:33881269
    supports: SUPPORT
    snippet: The article describes a case of 7-year-old child with rare Axenfeld-Rieger
      syndrome demonstrating the effectiveness and safety of combined laser reconstructive
      surgeries.
    explanation: The case report supports the use of laser and surgical therapy as
      part of the management for Axenfeld-Rieger syndrome.
  - reference: PMID:35733478
    supports: SUPPORT
    snippet: Treatment is predominantly the management of glaucoma and is mostly medical
      but can be surgical in refractory cases.
    explanation: Confirms that surgical management is used for refractory glaucoma
      cases in ARS.
- name: Dental Management
  description: Orthodontic and dental treatments to address dental anomalies including
    hypodontia, microdontia, and enamel hypoplasia. May include prosthetic reconstruction,
    dental implants, and orthodontic correction.
  treatment_term:
    preferred_term: surgical procedure
    term:
      id: MAXO:0000004
      label: surgical procedure
  evidence:
  - reference: PMID:22104715
    supports: SUPPORT
    snippet: The patient showed severe hypodontia, microdontia, and short roots. Different
      treatment options are discussed. Early diagnosis and an interdisciplinary approach
      are necessary to provide the best short- and long-term treatment plans, as well
      as treatment and follow-up for individuals with the syndrome.
    explanation: The reference discusses the dental anomalies in Axenfeld-Rieger syndrome
      and the importance of early diagnosis and interdisciplinary treatment, aligning
      with the statement about orthodontic and dental treatments to address these
      anomalies.
  - reference: PMID:33487449
    supports: SUPPORT
    snippet: The management of a Moroccan family with Axenfeld-Rieger syndrome.
    explanation: The reference indicates the management of Axenfeld-Rieger syndrome,
      which includes addressing dental anomalies, supporting the statement about orthodontic
      and dental treatments.
- name: Regular Ophthalmic Monitoring
  description: Frequent eye exams to monitor intraocular pressure, visual acuity,
    and anterior segment changes. Essential for early detection and management of
    glaucoma progression, particularly in pediatric patients.
  evidence:
  - reference: PMID:36926528
    supports: SUPPORT
    snippet: A multi-disciplinary approach including glaucoma specialists and pediatric
      ophthalmologists produces optimal outcomes as vision is dependent on many factors
      including glaucoma, refractive error, amblyopia and strabismus.
    explanation: The literature emphasizes the importance of regular ophthalmic monitoring
      for managing glaucoma and other ocular issues in Axenfeld-Rieger syndrome.
  - reference: PMID:33367186
    supports: SUPPORT
    snippet: Glaucoma is the main cause of visual morbidity in patients with ARS,
      therefore a complete periodic ophthalmological exam is a priority.
    explanation: This reference emphasizes the critical importance of regular comprehensive
      ophthalmologic examinations for ARS patients.
review_notes: Axenfeld-Rieger syndrome is a rare genetic disorder characterized by
  both ocular and systemic manifestations. The primary concerns are related to the
  increased risk of glaucoma and vision impairment, as well as craniofacial and dental
  anomalies. Early diagnosis and regular monitoring are essential for managing the
  condition effectively.
disease_term:
  preferred_term: Axenfeld-Rieger syndrome
  term:
    id: MONDO:0019187
    label: Axenfeld-Rieger syndrome
</pre>
            </div>
        </div>

        <footer class="page-footer">
            <p>
                Generated from <a href="https://github.com/monarch-initiative/dismech" target="_blank">dismech</a>
                knowledge base
            </p>
            <p style="margin-top: 8px;">
                <a href="https://github.com/monarch-initiative/dismech/blob/main/kb/disorders/Axenfeld-Rieger_syndrome.yaml" target="_blank">View source on GitHub</a>
            </p>
        </footer>
    </div>

    <script>
        function toggleYaml() {
            const content = document.getElementById('yamlContent');
            const toggleText = document.getElementById('yamlToggleText');
            content.classList.toggle('show');
            toggleText.textContent = content.classList.contains('show') ? 'click to hide' : 'click to show';
        }
    </script>
    <script>
        (function() {
            const banner = document.querySelector('.notice-banner');
            if (!banner) return;
            const dismiss = () => banner.remove();
            banner.addEventListener('click', dismiss);
            banner.addEventListener('keydown', (event) => {
                if (event.key === 'Enter' || event.key === ' ') {
                    event.preventDefault();
                    dismiss();
                }
            });
        })();
    </script>
</body>
</html>